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The question of whether and to what extent the in vivo
cytochrome c oxidase (COX) capacity in mammalian
cells exceeds that required to support respiration is still
unresolved. In the present work, to address this ques-
tion, a newly developed approach for measuring the rate
of COX activity, either as an isolated step or as a respi-
ratory chain-integrated step, has been applied to a va-
riety of human cell types, including several tumor-de-
rived semidifferentiated cell lines, as well as specialized
cells removed from the organism. KCN titration assays,
carried out on intact uncoupled cells, have clearly
shown that the COX capacity is in low excess (16–40%)
with respect to that required to support the endogenous
respiration rate. Furthermore, measurements of O2 con-
sumption rate supported by 0.4 mM tetramethyl-p-phe-
nylenediamine in antimycin-inhibited uncoupled intact
cells have given results that are fully consistent with
those obtained in the KCN titration experiments. Simi-
larly, KCN titration assays on digitonin-permeabilized
cells have revealed a COX capacity that is nearly limit-
ing (7–22% excess) for ADP 1 glutamate/malate-depend-
ent respiration. The present observations, therefore,
substantiate the conclusion that the in vivo control of
respiration by COX is much tighter than has been gen-
erally assumed on the basis of experiments carried out
on isolated mitochondria. This conclusion has impor-
tant implications for understanding the role of physio-
logical or pathological factors in affecting the COX
threshold.
In recent years, the metabolic control of oxidative phospho-
rylation has received growing attention, and the approach
based on the “control of flux” theory (1, 2) has been increasingly
applied to the study of mitochondrial metabolism since its first
use for such purpose (3). The discovery that mitochondrial DNA
mutations can cause diseases in humans (4, 5), affecting either
components of the translation apparatus or subunits of various
respiratory complexes, and the increasing evidence that a re-
duction in the activities of some respiratory chain complexes is
associated with aging or neurodegenerative diseases have
raised fundamental questions as to the degree of control that
the individual steps of oxidative phosphorylation exert on the
rate of mitochondrial respiration. Most of the experimental
work aimed at answering these questions has been carried out
by inhibitor titration experiments on isolated mitochondria and
has led to the conclusion that the activity of the various com-
ponents of the respiratory chain is in excess, sometimes a large
excess (2–4-fold), with evidence for a tissue-specific pattern,
over the rate required to support the endogenous respiration
rate (6–11). However, the issue has been recently raised as to
how accurately a metabolic control analysis applied to isolated
mitochondria can reflect the in vivo situation, considering the
possible loss of essential metabolites during organelle isolation
and the disruption of the normal interactions of mitochondria
with the cytoskeleton, which may be important for the chan-
neling of respiratory substrates to the organelles (12). The use
of a novel approach for the analysis of overall electron flux to
oxygen and of the control of respiration by cytochrome c oxidase
(COX)1 in intact cells has indeed revealed that the two related
wild-type cell lines tested exhibited only a slightly higher COX
capacity than required to support the endogenous respiration
rate (12). The cells analyzed in these studies were from appar-
ently undifferentiated established cell lines, and the tests were
done after uncoupling of respiration with dinitrophenol (DNP).
It therefore seemed important to apply the same type of anal-
ysis to differentiated or semidifferentiated cell types, and also
to apply this analysis under more physiological conditions
(state 3). This analysis has now been carried out and, as re-
ported in the present paper, fully supports the conclusion that
there is a low reserve of cytochrome c oxidase activity in vivo in
the respiratory chain of a variety of human cell types.
EXPERIMENTAL PROCEDURES
Cells and Culture Conditions—The osteosarcoma-derived cell line
143B.TK2 (13) was grown in Dulbecco’s modified Eagle’s medium
(DMEM) with 5% fetal bovine serum (FBS) and 100 mg/ml bromode-
oxyuridine. The SKO-007 (J3) human myeloma cell line (ATCC CRL-
8033–2) was grown in RPMI 1640 medium with 1 mM sodium pyruvate,
2 mM L-glutamine, 15% FBS, and 20 mg/ml 6-thioguanine. The A-549
human lung carcinoma cell line (ATCC CCL-185) was grown in DMEM
with 2 mM L-glutamine and 10% FBS. The HepG2 human hepatoma cell
line (ATCC HB-8065) was grown in DMEM 1 10% FBS. The SH-SY5Y
human neuroblastoma cell line (thrice-cloned subline of SK-N-SH
(ATCC HTB11) was grown in DMEM 1 15% FBS. The fibroblast strain
GM056059C from the Human Genetic Mutant Cell Repository (NIGMS,
National Institutes of Health), derived from a 14 month-old human
male individual, was grown in DMEM with 20% FBS. Myoblast cul-
tures derived from a normal human individual were grown in DMEM
with 15% FBS. Platelets were isolated from 17 ml of blood of a rabbit by
differential centrifugation and resuspended in 1.5 ml of TD (see below).
Measurement of Endogenous Respiration and DNP Titration of En-
dogenous Respiration in Intact Cells—Cells were collected, washed once
in Tris-based, Mg21-, Ca21-deficient (TD) buffer (0.137 M NaCl, 5 mM
KCl, 0.7 mM Na2HPO4, 25 mM Tris-HCl, pH 7.4, at 25 °C), resuspended
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in the same buffer previously air-equilibrated at 37 °C, and transferred
into a 1.5-ml water-jacketed Gilson chamber containing a small mag-
netic bar that was connected to a circulating water bath at 37 °C and a
YS model 5300 biological oxygen monitor (Yellow Springs Instruments).
After recording the endogenous respiration rate, the chamber was
opened; one sample was removed for cell counting, and, in some exper-
iments, four 20-ml samples were taken for total protein determination
by the Bradford procedure (14). For DNP titration, after recording the
coupled endogenous respiration rate, DNP was added at different con-
centrations, and the uncoupled respiratory rate was measured and
expressed as percentage of the starting coupled endogenous respiration
rate.
KCN Titration of COX Activity and Determination of COXR(max) and
TMPD-supported Respiration in Intact Uncoupled Cells—The KCN ti-
tration measurements and the determination of the maximum COX
capacity relative to the uninhibited endogenous respiration rate
(COXR(max)) from the threshold plots (i.e. the plots of relative endoge-
nous respiration rate against percentage of inhibition of isolated COX
activity at the same KCN concentrations) (7)) in DNP-uncoupled intact
cells were made as described previously (12). Similarly, the measure-
ments of the dependence on concentration of TMPD (0–2 mM), in the
presence of a constant concentration of ascorbate (10 mM), of the initial
O2 oxygen consumption rate associated with isolated COX activity in
DNP- and antimycin A-treated intact cells were carried out as detailed
in the above reference.
Digitonin Titration—Cells were collected; washed once in permeabi-
lization buffer containing 75 mM sucrose, 20 mM glucose, 5 mM KPi, 40
mM KCl, 0.5 mM EDTA, 3 mM MgCl2, 30 mM Tris (pH 7.4); resuspended
at 3–4 3 106 cells/ml in 1.5 ml of the same medium air-equilibrated at
37 °C; and supplemented with 5 units of hexokinase (type VI from
bakers yeast (Sigma)) (in order to promote synthesis of glucose 6-phos-
phate and thus prevent accumulation of ATP) and 0.5 mM ADP, and
transferred into the Gilson chamber. After recording the endogenous
respiration rate, 100 nM rotenone was added to block the endogenous O2
consumption, digitonin was added in different amounts from a 10%
solution in dimethyl sulfoxide, and after 2 min, 5 mM succinate was
added to measure the ADP-stimulated (state 3) rate of respiration of the
permeabilized cells. The optimal amount of digitonin was chosen as the
one giving the highest succinate-dependent respiration rate. This rate
did not increase upon addition of exogenous cytochrome c, thus showing
that the integrity of the mitochondrial outer membrane was preserved.
KCN Titration of COX Activity in Digitonin-permeabilized Cells—
Samples of 143B cells, hepatoma cells and fibroblasts were collected by
trypsinization and centrifugation and resuspended at about 3–4 3 106
cells/ml in permeabilization buffer supplemented with 1 mM phenyl-
methylsulfonyl fluoride, and digitonin was added at the optimal con-
centration (15 mg/106 cells for 143B cells, 10–15 mg/106 cells for fibro-
blasts (15), and 10 mg/106 cells for hepatoma cells). After 1–2 min,
digitonin was diluted by adding 5 volumes of the same buffer containing
0.3% bovine serum albumin. The cell suspension was then centrifuged,
and the cellular pellet was resuspended at 4–6 3 106 cells/ml in the
same buffer air-equilibrated at 37 °C and supplemented with hexoki-
nase (5 units) and 0.5 mM ADP. In the case of 143B cells and fibroblasts,
the inhibitor of adenylate kinase p1,p5-di(adenosine-59)pentaphosphate
(Ap5A, Sigma) was added, at 0.15–0.3 mM, to prevent dissipation of
ADP. This addition was shown, however, not to be necessary for the
KCN titration measurements. Finally, two 1.5-ml portions of each cell
suspension were transferred into 1.5-ml Gilson chambers attached to
the same circulating water bath and the same oxygen monitor. The
respiration measurements were then started by addition of 5 mM glu-
tamate and 5 mM malate for KCN titration of the integrated COX
activity, or of 20 mM antimycin A and either 10 mM ascorbate and 0.2
mM TMPD (143B cells) or 10 mM ascorbate plus 0.4 mM TMPD (hepa-
toma cells and fibroblasts), for KCN titration of the isolated COX
activity.
In the case of the myeloma cell line, cells were collected by centrif-
ugation, resuspended at 6–8 3 106 cells/ml and two 1.5-ml portions of
the suspension were transferred into the Gilson chambers as described
above. Digitonin was then added in the chambers at 5 mg/106 cells and,
after 3–5 min, O2 consumption measurements were started by addition
of 5 mM glutamate and 5 mM malate for KCN titration of the integrated
COX activity or of 20 mM antimycin A and 10 mM ascorbate and 0.4 mM
TMPD for KCN titration of the isolated COX activity.
RESULTS
Cell Types Analyzed—The cells or cell derivatives chosen for
analysis in the present work include several tumor-derived
human cell lines, the majority of which retain some or many of
the differentiated properties of the original tissue cell, such as
the hepatoma HepG2 cell line (16), the lung carcinoma A-549
cell line (17), the neuroblastoma SK-N-SH cell line (18), and the
SKO-007 (J3) myeloma cell line (19). Furthermore, differenti-
ated cells removed from normal individuals (myoblasts and
fibroblasts) and platelets from a rabbit were also analyzed.
Therefore, the cell types investigated covered a wide range of
specialized cells, and were expected to allow reasonably general
conclusions about the in vivo control of respiration by COX.
Measurements of Coupled and Uncoupled Endogenous Res-
piration Rate in Intact Cells—Previous work had shown that
the osteosarcoma-derived 143B.TK2 cell line (13) respires in a
Tris-NaCl-KCl-NaHPO4 buffer (TD buffer) at the same rate as
in DMEM lacking glucose (12). Table I shows the endogenous
respiration rate in TD of the various cell types investigated in
the present work as a function of the cell density reached by the
cultures at the time of analysis. It appears that, in all cell lines
analyzed, the O2 consumption rate per cell tended to decrease
TABLE I
Effect of cell concentration in culture on endogenous respiration rate per cell
Cell concentration in
culturea
Endogenous O2 consumption rate
b
fmol of O2/min/cell nmol of O2/min/mg of protein
cells/plate 3 1026 averagec
Osteosarcoma (143B.TK2) 7.6 (6) 3.3 12.7 12.7
Myeloma (SKO-007-J3) 2.5 (2) 2.3 6.8
3.3 (2) 2.6 NDd 6.9
4.0 (2) 1.5 7.0
Lung carcinoma (A-549) 2.1 (2) 4.5 13.7
10.4 (4) 2.6 12.9 13.1
Hepatoma (Hep-G2) 3.0 (2) 13.5 17.9
4.4 (2) 8.6 19.2
6.5 (2) 6.5 ND 15.5
9.0 (4) 6.3 12.5
Neuroblastoma (SHSY5Y) 2.8 (2) 2.6 ND
6.9 (4) 1.9 8.8 8.6
9.8 (2) 1.1 8.4
Fibroblasts (GM05659C) 1.8 (4) 1.6 3.8 3.8
a Measured at time of collection. The number of determinations is indicated in parentheses.
b Measured in TD buffer.
c Average of all determinations.
d Not determined.
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with increasing cell density. That this decrease was due to a
great extent to a decrease in size of the cells, presumably
associated with an arrest of cell growth in G1 phase, is shown
by the observation that the O2 consumption rate, normalized
per mg of protein, remained constant at different densities in
all cell lines, except for a slight decrease in hepatoma cells. The
endogenous respiration rates per mg of protein determined in
the different cell types investigated varied over a wide range,
from ;3.8 nmol of O2/min in fibroblasts to ;15.5 nmol of
O2/min in hepatoma cells.
In the present work, to exclude any effect of proton cycling
and oxidative phosphorylation on the respiratory flux, the
measurements were made in the presence of DNP. A titration
was made of the DNP concentration that produced the highest
stimulation of respiration. As exemplified in Fig. 1 for the
myeloma and hepatoma cells, striking differences were ob-
served in the titration curves obtained for the various cell
types. The values obtained in different cell types for the endog-
enous respiration rate and for the ratio of uncoupled respira-
tion rate, measured with the optimum DNP concentration, to
coupled respiration rate (uncoupled respiration ratio) are
shown in Table II. One can see that there is a large variation in
uncoupled respiration ratio, ranging between 1.17 for neuro-
blastoma cells and 1.90 for myeloma cells. It is interesting that
two normal cell types, fibroblasts and myoblasts, exhibited
uncoupled respiration ratio values falling within the range
observed for the various tumor-derived cell lines.
KCN Titration of COX Activity in Intact Cells—COX activity
in each of the cell types investigated here was titrated, as
described previously (12), with the specific inhibitor KCN both
as isolated step, using 0.4 mM TMPD and 10 mM ascorbate as
electron donors, in the presence of 20 nM antimycin A as up-
stream inhibitor, and as respiratory chain-integrated step (en-
dogenous respiration).
As examples of the analysis performed here, Fig. 2, a and c,
shows the KCN titration curves of COX activity as isolated step
and as integrated step for the myeloma and hepatoma cell
lines, respectively. The data are expressed as percentages of
DNP-uncoupled endogenous respiration rate. The differences
in the KCN titration curves of COX activity measured as iso-
lated step and as respiratory chain-integrated step are consist-
ent with the occurrence in the myeloma and hepatoma cells of
an excess of COX activity over that required to maintain a
normal O2 consumption rate, as previously observed for 143B
cells (12). This excess is best illustrated by the threshold plots
of Fig. 2, b and d, i.e. the plots of the relative endogenous
respiration rate of myeloma and hepatoma cells, respectively,
against the percentage of inhibition of isolated COX activity at
the same KCN concentrations.
Determination of Relative Maximum COX Capacity in Intact
Cells—In the plots shown in Fig. 2, b and d, if the least-square
regression line through the filled symbols beyond the inflection
point in each curve is extrapolated to zero COX inhibition, the
intersection with the ordinate axis should give an estimate of
the maximum COX capacity as integrated step, expressed as a
percentage of the uninhibited endogenous respiration rate (see
also Ref. 8). The COXR(max) values thus estimated for myeloma
cells and hepatoma cells are ;1.33 and ;1.16, respectively.
The COXR(max) values estimated for the different cell types
investigated in this work and for the previously analyzed 143B
cells (12) are shown in Table II. One can see that the excess of
maximum COX capacity over the endogenous respiration rates
varies between 1.16 times in hepatoma cells and 1.40 times in
143B cells, i.e. is much lower than previously reported for
isolated rat tissue mitochondria (6, 7, 9–11). The use of the
least-square regression lines through the points beyond the
inflection in the threshold plots for the calculation of the COX
thresholds is discussed below.
In previous work (12), the dependence on the concentration
of TMPD (0–2 mM), in the presence of a constant concentration
of ascorbate (10 mM), of the initial O2 consumption rate asso-
ciated with isolated COX activity was measured in DNP- and
antimycin A-treated 143B cells. This analysis showed that in
these cells, the uncoupled respiration rate supported by 0.4 mM
TMPD, expressed relative to the uncoupled endogenous respi-
ration rate, reached a value of 1.39, which was almost identical
to the COXR(max) value previously determined by KCN titration
for the same cells. This observation and the previous finding
that, in beef heart submitochondrial particles, the steady-state
level of reduction of cytochrome c reached a maximum at ;0.4
mM TMPD (20) suggested the possibility that measurement of
the relative uncoupled respiration rate supported by 0.4 mM
TMPD in DNP- and antimycin A-treated cells would provide a
simplified approach for the estimation of the COXR(max).
Fig. 3 shows the dependence on the concentration of TMPD
(from 0 to 2 mM), in the presence of a constant concentration of
ascorbate (10 mM) of the COX activity, measured as an isolated
step, in four of the cell types analyzed here, DNP- and antimy-
cin A-treated (myeloma, hepatoma, lung carcinoma, and neu-
roblastoma). Although in all curves, as already shown for 143B
cells (12), the TMPD is near-saturating above 2 mM, and starts
becoming limiting at '0.2 mM, as previously observed for an-
timycin A-inhibited beef heart isolated mitochondria (21), there
are some differences in the apparent saturation levels for the
different cell types. The relative uncoupled respiration rates in
0.4 mM TMPD were determined for the four human cell lines
analyzed in Fig. 3, as well as for human fibroblasts and myo-
blasts, and are shown in Table II.
One can see from Table II that the ratios of ascorbate 1 0.4
mM TMPD-dependent respiration rate to endogenous respira-
tion rate vary between 0.97 (for hepatoma cells) and 1.50 (for
myoblasts). A comparison with the corresponding COXR(max)
values determined by extrapolation of the KCN inhibition data
shows a remarkable similarity between the two sets of data
(within ;16%). Table II also shows the results of measure-
ments of the ratio of ascorbate 1 0.4 mM TMPD-dependent
respiration rate to endogenous respiration rate in rabbit plate-
FIG. 1. Titration of uncoupling effect of DNP. Samples of my-
eloma cells (2.7–3.3 3 106/ml) or hepatoma cells (3.3 3 106/ml) were
tested for O2 consumption rate in the presence of varying concentra-
tions of DNP. The data are expressed relative to the coupled endoge-
nous respiration rate set equal to 100%. Each symbol represents the
result of a single determination.
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lets, which gave a value of 1.42.
Relative COX Capacity in Human Cells in State 3—The
analysis of relative COX capacity described above was carried
out in uncoupled intact cells. It seemed, therefore, important to
test whether the conclusion reached about the nearly limiting
or low excess of COX activity in the respiratory chain of several
different human cell types also applies to cells permeabilized
with digitonin and tested in state 3 respiration, i.e. under more
TABLE II
Uncoupled to coupled respiration ratio (UCR), relative uncoupled respiration rate at 400 mM TMPD (AT 400/DNP end.resp.), relative COX
capacity (COXRmax), and COX threshold (COXT) in intact uncoupled cells (DNP) or in digitonin-permeabilized cells in state 3
See under “Experimental Procedures” for details.
UCRa AT 400/DNPend. resp.b
COXR(max) COXT
(DNP)
intact cellsc
(ADP 1 Glu/
Mal) permeable
cellsd
(DNP)
intact cellse
(ADP 1 Glu/
Mal) permeable
cellse
143B.TK2 1.35 1.39 6 0.03 1.40 1.22 28 18
Myeloma 1.90 6 0.03 1.14 6 0.01 1.33 1.15 25 13
Lung carcinoma 1.32 6 0.03 1.51 6 0.02 1.33 25
Hepatoma 1.65 6 0.03 0.97 6 0.02 1.16 1.20 14 17
Neuroblastoma 1.17 6 0.02 1.02 6 0.01 1.21 17
Fibroblasts 1.44 6 0.04 1.27 6 0.09 1.19 1.07 16 7
Myoblasts 1.50 6 0 1.50 6 0.05
Platelets (rabbit) 1.42
a Data derived from two or three independent experiments (three to eight determinations) and from Villani and Attardi (12) for 143B.TK2 cells.
The average and S.E. are shown.
b Data derived from one or two independent experiments (two to four determinations, one for platelets) and from Villani and Attardi (12) for
143B.TK2 cells.
c Data taken from experiments shown in Fig. 2, b and d, and similar experiments carried out with 143B.TK2 cells (12) with lung carcinoma cells
(three independent experiments, seven determinations), neuroblastoma cells (two experiments, four determinations), and fibroblasts (one
determination).
d Data taken from experiments shown in Fig. 5 and a similar experiment carried out with fibroblasts (one determination).
e Data derived from the COXR(max) values in this table.
FIG. 2. Inhibition by KCN of endogenous respiration rate in TD buffer in the presence of DNP (E) or of ascorbate 1 0.4 mM
TMPD-dependent respiration rate in TD buffer in the presence of DNP and antimycin A (l) in intact myeloma cells (a) or hepatoma
cells (c), and percentage of endogenous respiration rate as a function of percentage of COX inhibition in myeloma cells (b) or
hepatoma cells (d) with determination of maximum COX capacity (COXR(max)). a and c, the data of O2 consumption rate shown represent
the means 6 S.E. (the error bars that fall within the individual data symbols are not shown) obtained in four determinations (three independent
experiments) on myeloma cells and in seven determinations (two experiments) on hepatoma cells. The concentration of cells in the measuring
chamber was 2.7–3.3 3 106/ml for myeloma and 3.3 3 106/ml for hepatoma. b and d, the percentage rates of endogenous respiration in the
experiments illustrated in a and c, respectively, are plotted against percentage of COX inhibition by KCN, and the least-square regression line
through the filled symbols beyond the inflection point in each curve (arrow) is extended to zero COX inhibition. The equations describing these
extrapolated lines are shown.
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physiological conditions. Fig. 4 shows the curves illustrating
the succinate-supported respiration rate in hepatoma, my-
eloma, and 143B cells treated with different amounts of digi-
tonin. A digitonin concentration of 15 mg/106 cells was chosen
as optimal for 143B cells, 10 mg/106 cells, for hepatoma cells,
and 5 mg/106 cells, for myeloma cells. For fibroblasts, a concen-
tration of 10–15 mg/106 cells, as recommended by others (15),
was adopted. The state 3 (ADP-stimulated) glutamate/malate-
dependent respiration rates in digitonin-permeabilized 143B
cells, hepatoma cells, myeloma cells, and fibroblasts were found
to be very similar to the coupled endogenous respiration rates
of intact cells, thus allowing the titration of the same COX
activity under different metabolic conditions, but under com-
parable respiratory fluxes. Fig. 5 presents the threshold plots
for 143B, myeloma and hepatoma cells in state 3, showing that
the extrapolation of the least-square regression lines through
the filled symbols beyond the inflection point to zero COX
inhibition gives COXR(max) estimates of 1.22, 1.15, and 1.20,
respectively. Table II shows the COXR(max) value similarly es-
timated for fibroblasts. It is clear that the COXR(max) values
for state 3 of all cell types analyzed are very similar to the
COXR(max) values for the uncoupled state, with a tendency to be
somewhat lower (Table II). It has to be stressed, however, that
mitochondria (both in situ and as isolated organelles) have, in
state 3, a residual steady-state transmembrane electrochemi-
cal potential (Dp), which continues to exert its back pressure on
the electron flow through the whole respiratory chain or the
isolated cytochrome c oxidase. This has been verified, in our
experiments, by the observation of further stimulation of oxy-
gen consumption upon exposure to DNP of state 3-respiring
permeabilized cells (data not shown). This residual transmem-
brane electrochemical potential may account for the observa-
tion that the least-square regression lines through the symbols
beyond the inflection point in the curves of Fig. 5 do not ex-
trapolate to 100% COX inhibition.
DISCUSSION
The fundamental conclusion of this paper is that in a con-
siderable variety of human cell types, COX capacity, measured
in intact uncoupled cells or in digitonin-permeabilized cells in
state 3, appears to be in low excess or nearly limiting, respec-
tively, relative to the capacity needed to support endogenous or
glutamate/malate-dependent respiration. These observations
thus extend to a larger range of cell types and to a nearly
physiological situation (state 3 respiration) the conclusion,
previously suggested by observations on uncoupled 143B cells
and related pT3 cells (12), that the in vivo control of respiration
by cytochrome c oxidase is tighter than generally assumed. The
commonly held view of the occurrence in mammalian cells of a
relatively large excess (2–3-fold) of cytochrome c oxidase (7,
9–11, 22) was based on measurements made on isolated mito-
chondria. However, it has recently been emphasized that the
metabolic control analysis of respiration carried out in isolated
organelles can be limited by various factors, including the
possible loss of metabolites from mitochondria during isolation
and the nonphysiological conditions of substrate concentration
and delivery. An important additional factor that could influ-
ence the functional properties of isolated mitochondria is the
loss of interactions with the cytoskeleton (23, 24) and/or other
cellular organelles (25). A more physiological situation is at-
tained when mitochondria are analyzed in situ in permeabi-
lized systems, such as saponin- or glycerol-skinned muscle
fibers (26–28) and digitonin-permeabilized cells (15, 29). For
this purpose, we have optimized the digitonin permeabilization
conditions so as to obtain respiratory fluxes with NAD1-linked
substrates comparable to the coupled endogenous respiration
of intact cells. Under these conditions, permeabilized 143B
cells and fibroblasts exhibited respiratory control ratios as high
as 5–6, very close to the in vivo coupling values of oxidative
phosphorylation, measured in the same intact cells as ratios of
coupled respiration rate to oligomycin-inhibited respiration
FIG. 3. Dependence on concentration of TMPD, in the pres-
ence of a constant concentration of ascorbate, of the initial O2
consumption rate associated with isolated COX activity in DNP-
and antimycin A-treated lung carcinoma cells (L), myeloma
cells (O), neuroblastoma cells (M) and hepatoma cells (), ex-
pressed as a percentage of the uncoupled endogenous respira-
tion rate. The data shown represent the means 6 S.E. (the error bars
falling within the symbols are not shown) obtained in 2–4 determina-
tions (one or two independent experiments), utilizing 2.7–4 3 106
cells/ml in the measuring chamber.
FIG. 4. Titration of permeabilizing effect of digitonin. Samples
of hepatoma cells (3.3 3 106/ml), 143B.TK2 cells (3.0–3.5 3 106/ml) and
myeloma cells (2.7–3.3 3 106 cells/ml) were tested for succinate-depend-
ent respiration in the presence of varying concentrations of digitonin, as
detailed under “Experimental Procedures.” The data represent the re-
sults of single determinations on hepatoma cells or 143B.TK2 cells and
of two determinations on myeloma cells.
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rate.2 In this way, we could titrate COX activity avoiding a
possible overestimation of the maximum COX capacity due to
upstream inhibition of electron flux (as mimicked in 143B cells
partially inhibited with rotenone or antimycin; see Fig. 6 and
Ref. 12). The results obtained with permeabilized cells were
fully consistent with those obtained with intact cells.
An important relationship of the relative maximum COX
capacity is with the COX respiratory threshold (COXT), i.e. the
percentage of inhibition of isolated COX activity at which a
further decrease in enzyme activity has a marked inhibitory
effect on the rate of endogenous respiration. The equations
describing the extrapolated lines beyond the inflection point in
the threshold plots (Fig. 2, b and d) conform to the general
formula:
COXRi 5 COXR~max!~100 2 x! (Eq. 1)
where x represents the percentage of inhibition of COX activity
at [i] (concentration of inhibitor), as detected by KCN titration
of the isolation step, and Ri represents the endogenous respi-
ration rate at [i], expressed as a percentage of the uninhibited
endogenous respiration rate. From Equation 1, the threshold
value of x (COXT) at which COXRi 5 uninhibited endogenous
respiration rate (100%) (Fig. 2, b and d) can be calculated
according to the following equation:
COXT 5 100S1 2 1COXR~max!D (Eq. 2)
The COXT values thus determined for the cell types analyzed
in the present work, using either intact uncoupled cells or
digitonin-permeabilized cells in state 3, are shown in Table II.
In previous studies (12), a plot of the COXT values obtained by
Equation 2 from the KCN inhibition data for different cell lines
versus the independently obtained ratios of oxygen consump-
tion rate supported by 400 mM TMPD in the presence of 10 mM
ascorbate (AT400) to uncoupled endogenous respiration rate in
the same cell lines, used as estimators of their COXR(max)
values, had shown a nearly perfect fit to the curve representing
Equation 2. This result had confirmed the reliability of the
relative AT400 data for the estimation of COXR(max). Fig. 6a
shows that the COXT values and the ratios of AT400 to uncou-
pled endogenous respiration rate obtained for the cell types
analyzed in the present work fit well the same curve. No such
good fitting would be possible with values of relative uncoupled
respiration rate obtained at TMPD concentrations significantly
2 G. Villani and G. Attardi, unpublished results.
FIG. 6. Relationship of COX respiratory threshold (COXT) to
COXR(max) (a) and to cell protein content-normalized COX activ-
ity (b). a, the data for COXT obtained in the present work for lung
carcinoma cells (L), neuroblastoma cells (N), myeloma cells (M), hepa-
toma cells (H), and fibroblasts (F) () and those previously determined
(12) for 143B cells, pT3, pT1, and pT4 cells and for 3 nM rotenone- or 2.7
nM antimycin A-treated 143B cells (E) are plotted against the ratios of
ascorbate 1 0.4 mM TMPD-dependent O2 consumption rate to endoge-
nous respiration rate, used as estimators of COXR(max). See text for
details. b, the same data for COXT are plotted against the values of COX
activity promoted by 0.4 mM TMPD, expressed as nmol of O2/min/mg of
protein. For pT3, pT1, and pT4 cells, the same average value of mg of
protein/106 cells was used as for the parental 143B cells.
FIG. 5. Percentage of glutamate/malate-dependent respiration rate in digitonin-permeabilized 143B.TK2 cells (a), myeloma cells
(b), and hepatoma cells (c) as a function of percentage of COX inhibition, with determination of maximum COX capacity (state 3
COXR(max)). The least-square regression line through the filled symbols beyond the inflection point in each curve (arrow) was extended to zero COX
inhibition. The equations describing these extrapolated lines are shown.
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higher than 0.4 mM (data not shown). Particularly significant is
the clustering of all the values for the various cell types ana-
lyzed in the initial steep portion of the curve (estimated
COXR(max) between 1 and 1.5). The fairly large variation in
COXT (14–28%), corresponding to this COXR(max) range, has
important implications for the regulatory role of COX in mam-
malian cell respiration. In fact, it is obvious that in this narrow
range of relative COX capacity, any mutation or action of
inhibitor or change in physiological conditions that would affect
only moderately the activity of COX or of any of the components
of the respiratory chain upstream of COX could have a pro-
nounced effect on COXT and, therefore, on the control of respi-
ration by COX.
The importance of expressing the in vivo measurements of
COX activity relative to its in vivo utilization by the respiratory
flux is clearly illustrated by Fig. 6b, where the COXT values are
plotted versus the COX activity (AT400) expressed relative to
total cell protein. In fact, one can see that the scattered distri-
bution of the points does not reveal any relationship between
COX activity and the respiratory control exerted by the enzyme
in the various cell types.
One can raise the question as to whether the conclusion of
the occurrence of a low reserve of COX capacity, as observed in
cultured cells, can be extended to tissue cells in vivo. It is
interesting, in this connection, to compare our results with the
similar inhibitor titration analysis of COX activity that was
carried out on glycerol-skinned fibers from mouse quadriceps
and heart by Kuznetsov et al. (26). For this purpose, we have
plotted the azide titration data obtained by these authors on
permeabilized fibers respiring in state 3 in the presence of
glutamate 1 malate 1 succinate versus the azide titration data
of isolated COX activity obtained by the same authors in tissue
homogenates. The threshold plots obtained in this way gave
COXR(max) values of 1.26 and 1.29 and COXT values of 22 and
29% for mouse quadriceps and heart fibers, respectively. The
same analysis, when applied to the data by Kuznetsov et al.
(30) on saponin-skinned human muscle (vastus lateralis) fibers
respiring in state 3 with succinate, using, for the construction
of the inhibition curve of the isolated step, a KD value for azide
of 64 mM, as indicated by the same authors, resulted in a
COXR(max) value of 1.63 and a COXT value of 36%. It appears,
therefore, that the COXR(max) and COXT values that can be
calculated for fibers from the mouse and human muscles men-
tioned above from the published data fall in the same range
found in the cultured cells analyzed in the present work (Table
II and Fig. 6a).
Among the factors that have been shown to affect the flux
control of COX on respiration in saponin-permeabilized mouse
muscle fibers is the oxygen availability within the tissue (31),
with a significant increase in flux control having been observed
already at an oxygen concentration that is only ;30% lower
than the normoxic condition. Therefore, a slightly hypoxic state
of the affected muscles could make COX rate-limiting for res-
piration and, thus, account for the phenotype of mild COX
deficiency in muscle observed in several mitochondrial diseases
(30, 32, 33), in aging (34) and in COX-deficient mice (26).
Similarly, in patients with chronic cardiac ischemia, COX could
well become limiting for respiration.
A strong argument can be made that the proposed regulation
of COX activity by nucleotides and other allosteric effectors
(35–37) would be much more effective if COX were nearly
limiting relative to the endogenous respiration, as indicated by
the present results. Also, it has been shown that the H1/e2
stoichiometry of cytochrome c oxidase in rat liver mitochondria
(38) or of the purified beef-heart enzyme reconstituted in lipo-
somes (39, 40) varies under the influence of the respiratory
rate. This variation has a possible physiological role in rela-
tionship to the dependence of the oxidative phosphorylation
efficiency on the rate of electron flux crossing the proton
pumps, as shown in yeast mitochondria (41). For the purpose of
this kinetic control of the energy conservation properties of
COX (which is under the main control of the transmembrane
DpH), it would be advantageous for the cell to keep the COX
capacity within narrow limits of variation with respect to the
value at which the enzyme expresses the maximum proton
pumping efficiency. In particular, it seems plausible that this
value would be close to the level of COX activity required to
maintain endogenous respiration in tissues with a fairly con-
stant basal oxidative metabolism, as liver. Liver cells, in fact,
exhibited the lowest COXR(max) values among the cell types
tested in our work. On the other hand, in tissues with a very
high energy demand, which undergo continuous changes in
their oxidative metabolism, as is the case for heart and muscle,
a higher COXR(max) (as suggested by our relative AT400 data on
myoblasts) would be advantageous. In fact, it would allow an
adaptation to the variations in oxygen consumption rate in
order to keep the enzyme working under the best conditions of
energy coupling.
The finding in the present work of a low reserve of COX
capacity in vivo in the respiratory chain of a variety of human
cell types has also relevance to the recently discovered phenom-
enon of an early release of cytochrome c into the cytosol in cells
undergoing apoptosis (42–45). The cytochrome c/cytochrome c
oxidase molar ratio, measured in intact cells, has been found to
be 1.08 in isolated hepatocytes (46) and 1.62 in rat cardiac
myocytes (47). Therefore, the cytochrome c content does not
appear to be in large excess over that required for COX activity.
Accordingly, a massive loss of cytochrome c, combined with a
low COXR(max), in cells undergoing apoptosis may cause a dras-
tic decrease in respiration, with possible mechanistic implica-
tions for the execution of programmed cell death.
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